Q1 2020 Holdings
Filed 2020-05-15 | 51 holdings | $89.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arvinas Inc(ARVN) | COM | 04335A105 | $61.6M | 1,528,031 | 69.1% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $13.7M | 323,889 | 15.4% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $5.1M | 350,000 | 5.8% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $4.1M | 292,100 | 4.6% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $2.2M | 2,087,312 | 2.4% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $1.6M | 737,612 | 1.7% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $100.9K | 9,426,640 | 0.1% |
| Xencor Inc(XNCR) | COM | 98401F105 | $74.7K | 2,501,557 | 0.1% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $61.5K | 3,346,301 | 0.1% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $52.0K | 2,341,875 | 0.1% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $44.3K | 4,393,236 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $42.9K | 3,036,014 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $42.0K | 3,693,203 | 0.0% |
| Morphic Hldg Inc | COM | 61775R105 | $41.4K | 2,823,141 | 0.0% |
| Assembly Biosciences Inc | COM | 045396108 | $38.4K | 2,590,680 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $34.9K | 3,511,690 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $30.7K | 882,138 | 0.0% |
| Innate Pharma S A(IPHA) | SPONSORED ADS | 45781K204 | $29.8K | 4,465,668 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $27.5K | 357,849 | 0.0% |
| Prevail Therapeutics Inc | COM | 74140Y101 | $27.4K | 2,248,306 | 0.0% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $21.4K | 2,536,156 | 0.0% |
| Merus N V | COM | N5749R100 | $20.8K | 1,715,962 | 0.0% |
| Atreca Inc(BCELUSD) | CL A COM | 04965G109 | $18.3K | 1,106,180 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $16.5K | 371,208 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $14.7K | 2,308,079 | 0.0% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $13.9K | 653,981 | 0.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $12.2K | 698,101 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $11.5K | 1,249,611 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $11.1K | 4,597,701 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $9.9K | 208,609 | 0.0% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $9.3K | 270,418 | 0.0% |
| Ziopharm Oncology Inc | COM | 98973P101 | $9.2K | 3,750,000 | 0.0% |
| Verastem Inc | COM | 92337C104 | $8.6K | 3,255,813 | 0.0% |
| Bristol-Myers Squibb Co(BMY-R) | RIGHT 99/99/9999 | 110122157 | $8.5K | 2,248,300 | 0.0% |
| Cyclerion Therapeutics Inc(CYCNUSD) | COM | 23255M105 | $7.3K | 2,742,276 | 0.0% |
| Chiasma Inc(CHMA) | COM | 16706W102 | $5.5K | 1,512,627 | 0.0% |
| Exicure Inc(XCUR) | COM | 30205M101 | $4.2K | 2,841,301 | 0.0% |
| Savara Inc(SVRA) | COM | 805111101 | $3.0K | 1,432,664 | 0.0% |
| Lifesci Acquisition Corp | UNIT 03/31/2025 | 53228P208 | $3.0K | 300,000 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $2.4K | 1,274,463 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $1.5K | 41,407 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $1.3K | 30,510 | 0.0% |
| Meiragtx Holdings PLC(MGTX) | COM | G59665102 | $1.3K | 94,819 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $1.2K | 291,997 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $1.0K | 50,809 | 0.0% |
| Regulus Therapeutics Inc | COM NEW | 75915K200 | $870 | 1,886,812 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $816 | 13,946 | 0.0% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $602 | 264,166 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $581 | 256,075 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $108 | 6,269 | 0.0% |